Disease Markers

Biomarkers of Cardiovascular Disease


Publishing date
10 Mar 2017
Status
Published
Submission deadline
21 Oct 2016

Lead Editor

1Cleveland Clinic, Cleveland, USA

2Riverside Medical Clinic, Riverside, USA

3Cleveland State University, Cleveland, USA


Biomarkers of Cardiovascular Disease

Description

Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality in most developed countries. CVD prevalence is also rapidly increasing in developing countries, where the limited identification and treatment options led to frequent unreported cases. Thus, improved strategies for the prevention and treatment of CVD are a worldwide public health priority. Unlike other disease areas, access to tissue samples for diagnostic or prognostic purposes is extremely limited in cardiovascular diseases. Despite overwhelming numbers of studies on biomarkers related to CVD, none of the biomarkers alone significantly improved differentiation between cases and controls. Traditional risk factors (cigarette smoking, diabetes, hyperlipidemia, and hypertension) are identified in only a subset of individuals who develop cardiovascular diseases. There is an urgent need to identify novel risk markers for cardiovascular diseases for better risk prediction and development of evidence based novel therapies.

We invite investigators to contribute original research articles as well as review articles about the discovery of novel biomarkers and management of current biomarkers of cardiovascular diseases.

Potential topics include, but are not limited to:

  • Novel biomarkers and genetic risk factors in gaining mechanistic insight into CVD pathogenesis
  • New application of existing biomarkers
  • Strategies for the discovery and validation of biomarkers in body fluids; the latest technologies in the field of integrated biomarker assessment and qualification in the context of diagnosis, treatment, and prevention of cardiovascular diseases
  • The latest clinical data associated with biomarkers in cardiovascular disease risk prediction and clinical management of disease

Articles

  • Special Issue
  • - Volume 2017
  • - Article ID 9134079
  • - Research Article

Plasma IL-37 Elevated in Patients with Chronic Heart Failure and Predicted Major Adverse Cardiac Events: A 1-Year Follow-Up Study

Xiling Shou | Jing Lin | ... | Chaofeng Sun
  • Special Issue
  • - Volume 2017
  • - Article ID 5692583
  • - Review Article

Ischemia-Modified Albumin as a Marker of Acute Coronary Syndrome: The Case for Revising the Concept of “N-Terminal Modification” to “Fatty Acid Occupation” of Albumin

Ismail Oran | Bulent Oran
  • Special Issue
  • - Volume 2017
  • - Article ID 8784971
  • - Review Article

Crosstalk between Vitamins A, B12, D, K, C, and E Status and Arterial Stiffness

Ioana Mozos | Dana Stoian | Constantin Tudor Luca
  • Special Issue
  • - Volume 2017
  • - Article ID 4343171
  • - Research Article

Parathyroid Hormone Levels in the Prediction of Ischemic Stroke Risk

Güner Çelik | Ali Doğan | ... | Hakan Ekmekçi
  • Special Issue
  • - Volume 2016
  • - Article ID 9085474
  • - Research Article

Insulin Resistance in Adipose Tissue but Not in Liver Is Associated with Aortic Valve Calcification

Esteban Jorge-Galarza | Carlos Posadas-Romero | ... | Juan G. Juárez-Rojas
  • Special Issue
  • - Volume 2016
  • - Article ID 5965782
  • - Research Article

Handheld Capillary Blood Lactate Analyzer as an Accessible and Cost-Effective Prognostic Tool for the Assessment of Death and Heart Failure Occurrence during Long-Term Follow-Up

Grzegorz M. Kubiak | Wojciech Jacheć | ... | Ewa Nowalany-Kozielska
  • Special Issue
  • - Volume 2016
  • - Article ID 7169531
  • - Research Article

Relationship between Serum Levels of Metalloproteinase-8 and Tissue Inhibitor of Metalloproteinases-1 and Exercise Test Results in Postmenopausal Women

J. Mieczkowska | E. Rutkowska | ... | B. Mosiewicz
  • Special Issue
  • - Volume 2016
  • - Article ID 8489543
  • - Research Article

Is Urinary NGAL Determination Useful for Monitoring Kidney Function and Assessment of Cardiovascular Disease? A 12-Month Observation of Patients with Type 2 Diabetes

Agnieszka Żyłka | Agnieszka Gala-Błądzińska | ... | Beata Kuśnierz-Cabala
  • Special Issue
  • - Volume 2016
  • - Article ID 2872507
  • - Review Article

Platelets miRNA as a Prediction Marker of Thrombotic Episodes

Michal Bijak | Malgorzata Dzieciol | ... | Marzenna Zielinska
Disease Markers
 Journal metrics
Acceptance rate34%
Submission to final decision88 days
Acceptance to publication43 days
CiteScore3.500
Impact Factor2.738
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.